although
outbreak
coronaviru
diseas
caus
death
china
studi
death
yet
aim
describ
clinic
characterist
nonsurvivor
retrospect
singlecent
studi
includ
nonsurvivor
fifth
hospit
wuhan
case
confirm
realtim
rtpcr
jan
feb
accord
recommend
protocol
epidemiolog
demograph
clinic
laboratori
radiolog
treatment
data
collect
analyz
outcom
follow
feb
studi
approv
ethic
commiss
fifth
hospit
wuhan
waiver
inform
consent
due
public
health
outbreak
investig
includ
patient
die
covid
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
lot
patient
die
till
median
surviv
time
nonsurvivor
onset
death
week
patient
older
male
comorbid
final
progress
ard
median
time
onset
ard
day
gradual
decreas
lymphocyt
increas
inflamm
biomark
common
need
monitor
routin
treatment
funder
involv
studi
outbreak
coronaviru
diseas
caus
sever
acut
respiratori
syndrom
coronaviru
happen
sinc
decemb
wuhan
spread
china
well
countri
outbreak
infect
declar
public
health
emerg
intern
concern
world
health
organ
januari
accord
situat
report
februari
infect
caus
confirm
case
countri
death
global
sever
vari
mild
sever
mortal
rate
reduc
time
identifi
higher
risk
develop
critic
ill
patient
close
monitor
chang
diseas
cours
appli
intens
care
treatment
patient
howev
report
dead
case
limit
warrant
consid
larg
amount
confirm
case
still
increas
singlecent
studi
retrospect
analys
specif
clinic
inform
nonsurvivor
infect
retrospect
singlecent
studi
includ
nonsurvivor
fifth
hospit
wuhan
case
confirm
jan
feb
accord
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
recommend
protocol
studi
approv
ethic
commiss
hospit
waiver
inform
consent
due
public
health
outbreak
investig
confirm
realtim
rtpcr
use
protocol
describ
previous
addit
patient
given
chest
comput
tomographi
ct
obtain
epidemiolog
demograph
clinic
laboratori
treatment
outcom
data
patient
medic
record
clinic
outcom
follow
feb
analys
epidemiolog
demograph
exposur
histori
smoke
histori
chronic
medic
ill
sign
symptom
admiss
comorbid
chest
ct
find
laboratori
find
treatment
measur
categor
variabl
describ
count
continu
variabl
describ
use
mean
sd
normal
distribut
median
iqr
statist
analys
perform
use
r
version
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
includ
patient
die
fifth
hospit
wuhan
one
patient
histori
exposur
huanan
seafood
market
wuhan
mean
age
patient
year
sd
rang
twentyf
patient
male
femal
four
patient
smoke
histori
twentysix
patient
chronic
diseas
common
chronic
diseas
hypertens
cardiovascular
diabet
tabl
admiss
patient
fever
cough
half
short
breath
tabl
symptom
includ
fatigu
dyspnea
sputum
product
disturb
conscious
diarrhea
hemoptysi
myalgia
tabl
accord
chest
ct
scan
patient
show
bilater
pneumonia
admiss
leucocyt
normal
rang
patient
normal
rang
patient
tabl
neutrophil
show
normal
rang
patient
lymphocyt
hemoglobin
normal
rang
mani
patient
tabl
twelv
patient
platelet
normal
rang
patient
vari
degre
liver
function
abnorm
alanin
aminotransferas
alt
aspart
aminotransferas
ast
rose
normal
rang
tabl
elev
lactat
dehydrogenas
show
patient
patient
differ
degre
renal
function
damag
elev
blood
urea
nitrogen
serum
creatinin
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
regard
infect
index
procalcitonin
pct
rose
normal
rang
patient
patient
test
whose
index
normal
rang
tabl
patient
increas
creactiv
protein
crp
thirtyf
patient
receiv
antivir
treatment
includ
oseltamivir
ganciclovir
ribavirin
umifenovir
hydrochlorid
patient
given
antibiot
treatment
tabl
tabl
median
time
onset
death
day
figur
report
patient
die
infect
singl
hospit
wuhan
patient
ard
patient
need
mechan
ventil
bilater
pneumonia
detect
patient
admiss
previou
studi
shown
elder
patient
male
confirm
coronaviru
infect
higher
risk
ard
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
consist
studi
antibiot
treatment
use
prevent
secondari
infect
sinc
patient
critic
ill
antivir
regim
also
use
patient
hope
may
role
still
need
data
howev
specif
remedi
yet
therefor
patient
treat
support
treatment
intens
care
unfortun
due
restrict
hospit
condit
heavi
burden
wuhan
citi
neither
abl
provid
patient
need
advanc
life
support
system
like
extracorpor
membran
oxygen
ecmo
abl
transport
seriou
patient
superior
hospit
better
medic
treatment
time
median
surviv
time
patient
studi
week
approxim
shorter
compar
previou
report
decreas
clinic
capac
improv
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
report
previou
studi
patient
male
elder
histori
cerebrovascular
diseas
higher
risk
infect
studi
found
major
coronaviru
nonsurvivor
male
patient
elder
patient
patient
chronic
diseas
indic
patient
might
also
increas
risk
becom
critic
ill
death
cerebrovascular
diseas
common
comorbid
twentytwo
nonsurvivor
cerebrovascular
diseas
report
percentag
cerebrovascular
diseas
among
nonsurvivor
higher
report
yang
et
al
besid
nonsurvivor
smoke
histori
preexist
copd
accord
previou
studi
middl
east
respiratori
syndrom
coronaviru
merscov
smoker
copd
patient
might
suscept
mer
compar
nonsmok
smoker
copd
patient
higher
dipeptidyl
peptidas
iv
express
invers
correl
lung
function
diffus
capac
paramet
although
relationship
smoke
histori
suscept
well
wors
outcom
remain
unclear
caution
prognosi
patient
smoke
histori
might
sever
cohort
lymphocytopenia
occur
patient
admiss
main
laboratori
featur
patient
lymphocytopenia
identifi
critic
ill
patient
sarscov
mer
infect
mention
previou
studi
sever
lymphocytopenia
might
indic
sever
assumpt
viral
could
attack
destroy
lymphocyt
targetedli
studi
warrant
confirm
find
increas
level
serum
crp
pct
also
found
indic
obviou
inflammatori
respons
among
patient
addit
notic
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
increas
crp
pct
concentr
decreas
lymphocyt
count
admiss
death
supplementari
figur
may
repres
promin
inflamm
sever
patient
therefor
intraven
glucocorticoid
therapi
intraven
immunoglobulin
therapi
interferonalpha
aerosol
inhal
also
use
restor
homeostasi
without
solid
evid
knowledg
still
specif
medicin
till
clinic
trial
promis
regimen
remdesivir
lopinavir
chloroquin
phosphat
ongo
shed
light
conquer
epidem
studi
sever
limit
first
dead
case
includ
howev
largest
cohort
nonsurvivor
second
specif
clinic
inform
insuffici
mechan
ventil
set
oxygen
concentr
detail
medic
histori
third
retrospect
singlecent
studi
may
limit
hospit
critic
care
resourc
studi
still
need
conclus
nonsurvivor
older
men
comorbid
especi
cardiovascular
diseas
final
progress
ard
median
time
onset
ard
day
mean
surviv
time
cohort
nonsurvivor
week
gradual
decreas
lymphocyt
increas
inflamm
biomark
found
patient
need
monitor
routin
treatment
earli
detect
intervent
patient
especi
import
delay
develop
mild
sever
case
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
yh
ry
yx
collect
epidemiolog
clinic
data
yh
summaris
data
yh
ry
yx
pg
draft
manuscript
yh
pg
revis
final
manuscript
declar
compet
interest
data
made
avail
other
reason
request
correspond
author
deidentifi
particip
data
provid
approv
correspond
author
fifth
hospit
wuhan
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
authorfund
grant
medrxiv
licens
display
preprint
perpetu
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
